• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Antipsychotics in Inpatient Children and Adolescents with Seclusion and Restraint
Research Update

Antipsychotics in Inpatient Children and Adolescents with Seclusion and Restraint

August 1, 2023
Susie Morris, MD.
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Susie Morris, MD. Dr. Morris has no financial relationships with companies related to this material

REVIEW OF: Albers C et al, J Child Adolesc Psychopharmacol 2021;31(5):358–363

STUDY TYPE: Retrospective review

Antipsychotic agents are increasingly used for children and adolescents in psychiatric inpatient units. These medications’ tranquilizing effects are thought to decrease the length of time that kids require seclusion and restraints (S&R)—but is this actually true? 

To examine this question, the authors conducted a retrospective analysis of the impact of antipsychotic use on duration of S&R in a pediatric inpatient cohort (n=96). Subjects consisted of children ages 5–17 who were hospitalized at the University of Missouri’s pediatric inpatient psychiatric unit between 2012 and 2014 and required S&R during their hospitalizations. Diagnoses included mood, anxiety, developmental, cognitive, and behavioral disorders. 

Patients who received antipsychotic medications spent significantly more time in S&R compared to patients who did not receive medications (p=0.001) or patients who received medications other than antipsychotics, such as diphenhydramine (p=0.002). Female patients were almost three times more likely than male patients to receive antipsychotic medications while in S&R. Average times spent in S&R for the antipsychotic group, other-medication group, and no-medication group were 76 minutes, 54 minutes, and 44 minutes, respectively. 

It’s possible that patients who received antipsychotics were more agitated in the first place, thus requiring longer time in S&R. Alternatively, they may have first received other medications that were found to be ineffective, then subsequently placed on antipsychotics. The study did not include information on the severity of subjects’ agitation and did not provide time-based data on the administration of medications—two significant limitations. 

The authors acknowledged that their findings are preliminary and require further exploration. They encouraged alternative strategies, like behavioral approaches and milieu management, until more is known about antipsychotics’ effectiveness for this population—particularly since kids are uniquely vulnerable to side effects like neuroleptic malignant syndrome, dystonia, and metabolic derangements. 

Carlat Take

This study reports that antipsychotic medications don’t reduce kids’ time in S&R. Many factors confound these findings, but until we have better data on the efficacy of antipsychotics in this context, it’s reasonable to try alternative interventions like behavioral ­approaches.

Hospital Psychiatry Research Update
KEYWORDS adolescents agitation antipsychotics inpatient
    Susie Morris, MD.

    Psychogenic Non-Epileptic Seizures

    More from this author
    www.thecarlatreport.com
    Issue Date: July 31, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Child & Adolescent Psychiatry, CHPR, July/August/September 2023
    Psychiatric Consultation to Children and Adolescents on Pediatric Units: A Primer
    Management of Aggressive Behavior in Children and Adolescents on the Inpatient Unit and Emergency Department
    Crisis in Pediatric Mental Health: The Kids Aren’t Alright
    Suicide in Children and Adolescents
    Antipsychotics in Inpatient Children and Adolescents with Seclusion and Restraint
    CME Post-Test, Child and Adolescent Psychiatry, CHPR, July/August/September 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.